Screener / SEC EDGAR /CIK 0001828318 /10-K filed Feb 25, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Miscellaneous Electrical Machinery, Equipment & Supplies

Enovix Corp ENVX

Compare with peers Embed
SEC comment letters, last 20 years

4 reviews of ENVX's filings by SEC staff

UPLOAD and CORRESP
Reviews 4 latest letter Jul 25, 2024
Questions asked 47 each answered in the company's own letter
No closing letter 3 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 6 UPLOAD
  2. 2. Questions in them 47 numbered comments
  3. 3. Company replies 9 CORRESP
  4. 4. Reviews closed 1 of 4 closing letter

Half the closed reviews took 18 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended December 31, 2023

2024-07-25 to 2024-08-12 · 5 questions · 1 letter from the SEC, 1 from the company
Review closed 2024-08-12
RevenueNon-GAAP measuresLiquidity and cashSegments
Note 2. Summary of Significant Accounting Policies · Revenue Recognition, page 80
SEC asked (1)
Please revise your disclosures related to Product Revenue to clarify when you satisfy each performance obligation (i.e., when control transfers) as required by ASC 606-10-50-12(a).
ENVX answered
This letter is in response to the comments contained in the letter from the Staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “SEC”), dated July 25, 2024, with respect to the above-referenced filings of Enovix Corporation (“Enovix” or the “Company”). Set forth below are the Staff’s comments in italics, followed in each case by the response of the Company. Notes to the Consolidated Financial Statements Note 2.
Rest of the letter

Summary of Significant Accounting Policies, Revenue Recognition, page 80 Please revise your disclosures related to Product Revenue to clarify when you satisfy each performance obligation (i.e., when control transfers) as required by ASC 606-10-50-12(a). In response to the Staff’s comment, we will revise and expand our disclosure to include information on how we meet our performance obligations as required by ASC 606-10-50-12(a) in our future filings, commencing with the Form 10-K for the fiscal year ending December 29, 2024, substantially as follows: “Our product revenue mainly relates to sales of lithium-ion batteries or battery packs. We recognize our product revenue at a point in time when the performance obligation has been satisfied upon transfer of control of goods, which is upon product shipment, delivery or customer acceptance, depending on the specific contract terms. For certain customized products with customer acceptance criteria specified in the contract, the performance obligation is satisfied upon our customer’s formal acceptance.” Note 18. Geographic Information, page 111 We note your disclosure of disaggregated revenues by geographic areas. Please tell us how you considered the guidance to further disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors, e.g., type of revenue (i.e., product and service) and timing (i.e., at a point in time and over time). Refer to ASC 606-10-50-5 and also see ASC 606-10-55-89 through 91. We acknowledge the Staff’s comment and will expand our disclosure to include information on disaggregation of revenue in our future filings commencing with the Form 10-K for the fiscal year ending December 29, 2024, substantially as shown in the following table (in thousands). As disclosed in the Form 10-K for the fiscal year ended December 31, 2023, our revenue recognition for service and product revenue is at a point in time. For fiscal year 2021, there was no revenue. For fiscal year 2022, our total revenue primarily consisted of service revenue. For fiscal year 2023, we only had product revenue, which was primarily from lithium-ion batteries and battery packs. In addition to the previous comment, please address the following: • Clarify whether revenues by geographic areas represent revenues from external customers for each reporting period. • Disclose the amount of revenues from external customers attributed to and the amount of long-lived assets in an individual foreign country, if material. Refer to ASC 280-10-50-41. • Update your disclosure that you do not have material activity or assets located outside of the U.S. on page 75 to remove inconsistencies. Our responses below are corresponding to the same order as the bullet points in the Staff’s comment above: •Our revenues for both fiscal years 2023 and 2022 were solely from our external customers. We did not have revenue for fiscal year 2021. •We provide the revenues and long-lived assets by individual foreign country, if material, below in accordance with ASC 280-10-50-41. We will disclose such information in our future filings commencing with the Form 10-K for the fiscal year ending December 29, 2024. 3501 W. Warren Blvd. | Fremont, CA 94538 | USA | www.enovix.com The following table summarizes our revenues from the following countries based on the billing location of the customers (in thousands). Our long-lived assets primarily consist of property and equipment and operating lease right-of-use assets. The following tables summarize these assets by the countries (in thousands). Total property, equipment, net $ 166,471 $ 103,868 Total operating ROU assets, net $ 15,290 $ 6,133 •We acknowledge the Staff’s comment and will revise our disclosures going forward to ensure we provide consistent disclosure regarding our material assets and activities located outside the U.S. commencing with our Form 10-K for the fiscal year ending December 29, 2024. We note you present and discuss adjusted EBITDA before you present and discuss the most directly comparable GAAP measure. Please revise the order of your disclosures to present GAAP measures with equal or greater prominence as required by Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 of the Division of Corporation Finance’s Compliance & Disclosure Interpretations on Non-GAAP Financial Measures. We acknowledge the Staff’s comment and confirm that we have considered the guidance in Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 of the Division’s Non-GAAP Financial Measures Compliance & Disclosure Interpretations. In response to the Staff’s comment, we will revise the order of our disclosures to present and discuss GAAP measures with equal or greater prominence to adjusted EBITDA and other non-GAAP measures for our future filings, including press release and shareholder letters. For example, please refer to Exhibit 99.1 to our Form 8-K (“Q2 Shareholder Letter”), furnished on July 31, 2024, in which we present and discuss GAAP net loss attributable to Enovix prior to presenting adjusted EBITDA. We note you provide a range of forward-looking adjusted EBITDA loss and non-GAAP EPS loss without providing reconciliations to the most directly comparable GAAP measures or a statement that providing such reconciliations requires unreasonable efforts. In future filings, please provide reconciliations to the most directly comparable GAAP measures. If all of the information necessary for the reconciliations is not available without unreasonable efforts, identify and disclose the information that is unavailable and its probable significance. Also present the most directly comparable GAAP measures with equal or greater prominence. Refer to Item 10(e)(1)(i) of Regulation S-K and Questions 102.10(a), 102.10(b), and 103.02 of the Staff’s Compliance and Disclosure Interpretations on Non-GAAP Financial Measures. In addition, revise your future other public disclosures, such as letters to shareholders, to provide reconciliations to the most directly comparable GAAP measure for each forwardlooking non-GAAP measure presented or a statement that providing such reconciliations requires unreasonable efforts. See Rule 100(a)(2) of Regulation G. We acknowledge the Staff’s comment and respectfully advise the Staff that, after careful consideration of the applicable guidance, we have determined that the information necessary for a reconciliation of such forward-looking non-GAAP measures is not available without unreasonable efforts. Specifically, we have determined that the information necessary for a reconciliation for the projected ranges of adjusted EBITDA loss and non-GAAP earnings per share loss for the third quarter of 2024 is not available without unreasonable efforts because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including warrant liabilities and stock- based compensation. We have included a disclaimer statement in the Non-GAAP Financial Measures section of our Q2 Shareholder Letter. We acknowledge the Staff’s comment as it relates to future public disclosures. In response to the Staff’s comment, we will ensure that our future Shareholder Letters and other public disclosures provide a reconciliation to the most directly comparable GAAP measure for any forward-looking non-GAAP measure presented, or include a statement that providing such reconciliation would require unreasonable efforts. The Company believes that the foregoing responds fully to each of the Staff’s comments. Please advise us if you have any questions about our responses.

One letter for all the questions, without numbered answers. Read the reply
In its next report

First report after the company's reply of Aug 8, 2024: 10-Q filed Oct 30, 2024 ↗, against the 10-Q filed May 7, 2024 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 18. Geographic Information, page 111
SEC asked (2)
We note your disclosure of disaggregated revenues by geographic areas. Please tell us how you considered the guidance to further disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors, e.g., type of revenue (i.e., product and service) and timing (i.e., at a point in time and over time).
Rest of the question

Refer to ASC 606-10-50-5 and also see ASC 60610-55-89 through 91.

ENVX answered

See the reply above.

In its next report

First report after the company's reply of Aug 8, 2024: 10-Q filed Oct 30, 2024 ↗, against the 10-Q filed May 7, 2024 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 18. Geographic Information, page 111
SEC asked (3)
In addition to the previous comment, please address the following: • Clarify whether revenues by geographic areas represent revenues from external customers for each reporting period. • Disclose the amount of revenues from external customers attributed to and the amount of long-lived assets in an individual foreign country, if material. Refer to ASC 280-10-50-41.
Rest of the question

• Update your disclosure that you do not have material activity or assets located outside of the U.S. on page 75 to remove inconsistencies.

ENVX answered

See the reply above.

In its next report

First report after the company's reply of Aug 8, 2024: 10-Q filed Oct 30, 2024 ↗, against the 10-Q filed May 7, 2024 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Exhibit 99.1, page 3
SEC asked (4)
We note you present and discuss adjusted EBITDA before you present and discuss the most directly comparable GAAP measure. Please revise the order of your disclosures to present GAAP measures with equal or greater prominence as required by Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 of the Division of Corporation Finance’s Compliance & Disclosure Interpretations on Non-GAAP Financial Measures.
ENVX answered

See the reply above.

In its next report

First report after the company's reply of Aug 8, 2024: 10-Q filed Oct 30, 2024 ↗, against the 10-Q filed May 7, 2024 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Exhibit 99.1, page 3
SEC asked (5)
We note you provide a range of forward-looking adjusted EBITDA loss and non-GAAP EPS loss without providing reconciliations to the most directly comparable GAAP measures or a statement that providing such reconciliations requires unreasonable efforts. In future filings, please provide reconciliations to the most directly comparable GAAP measures.
Rest of the question

If all of the information necessary for the reconciliations is not available without unreasonable efforts, identify and disclose the information that is unavailable and its probable significance. Also present the most directly comparable GAAP measures with equal or greater prominence. Refer to Item 10(e)(1)(i) of Regulation S-K and Questions 102.10(a), 102.10(b), and 103.02 of the Staff’s Compliance and Disclosure Interpretations on Non-GAAP Financial Measures. In addition, revise your future other public disclosures, such as letters to shareholders, to provide reconciliations to the most directly comparable GAAP measure for each forwardlooking non-GAAP measure presented or a statement that providing such reconciliations requires unreasonable efforts. See Rule 100(a)(2) of Regulation G. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

ENVX answered

See the reply above.

In its next report

First report after the company's reply of Aug 8, 2024: 10-Q filed Oct 30, 2024 ↗, against the 10-Q filed May 7, 2024 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2024-08-12

Form S-3

2023-11-20 to 2023-12-01 · 1 question · 1 letter from the SEC, 2 from the company
No closing letter
SEC asked
Please disclose the nature of any position, office or other material relationship that the selling stockholder has had within the past three years with you or any of your predecessors or affiliates. Additionally, disclose Item 507 information about any persons (entities or natural persons) who have control over the selling stockholder and who have had a material relationship with you or any of your predecessors or
Rest of the question

affiliates within the past three years, identifying each such person and describing the nature of any relationships. See Item 507 of Regulation S-K. For additional guidance, refer to Question 140.02 of our Regulation S-K Compliance and Disclosure Interpretations.

ENVX answered
to the Staff’s comment, the Company respectfully advises the Staff that it has revised the disclosure on page 12 of Amendment

No. 1.

***

Cooley

LLP 3175 Hanover Street Palo Alto, CA 94304-1130 t: +1 650 843 5000 f:
Read in the reply

Also in this review: company letter, Dec 1, 2023

Form S-4

2021-04-05 to 2021-06-21 · 40 questions · 3 letters from the SEC, 3 from the company
No closing letter
AcquisitionsRisk factorsResults discussion (MD&A)Income taxesRevenue
General
SEC asked (1)
Please revise to limit your cover page in accordance with Item 501(b) of Regulation S-K.
ENVX answered
The Company acknowledges the Staff’s comment and has revised the cover page of the Amended Registration Statement as requested.
Read in the reply
General
SEC asked (2)
Please disclose the financial projections and assumptions for Enovix.
ENVX answered
The Company acknowledges the Staff’s comment and has disclosed the financial projections and assumptions for Enovix beginning on page 93 of the Amended Registration Statement.
Read in the reply
Questions and Answers About the Proposals · Q: Are there any arrangements to help ensure that RSVAC will have sufficient funds..., page 6
SEC asked (3)
We note your disclosure regarding your anticipated uses of the funds from the trust. Please revise to clarify how the PIPE funds will be used. Q: What interests do RSVAC's current officers and directors have in the Business Combination?,
ENVX answered
The Company acknowledges the Staff’s comment and has updated the disclosure on page 6 of the Amended Registration Statement to clarify how the PIPE funds will be used.
Read in the reply
Questions and Answers About the Proposals · Q: Are there any arrangements to help ensure that RSVAC will have sufficient funds..., page 6
SEC asked (4)
Please provide the amount of out-of-pocket expenses that have been incurred. Please also quantify the interests that each of your sponsor, current officers and directors will receive in the business combination by listing the value of the securities as of the most recent practicable date. Include the PIPE investors in your discussion. Please make similar changes throughout the proxy statement/prospectus.
ENVX answered
The Company acknowledges the Staff’s comment and has updated the disclosure in all relevant places throughout the Amended Registration

Statement to quantify the interests that each of the sponsor, current officers and directors will receive in the business combination, the out of pocket expenses and the value of the securities as of the most recent practicable date.

As discussed during our telephone call on April 7, 2021, we understand the concerns underlying the Staff’s request to include the PIPE Investors interests may not have been relevant in this transaction because the PIPE Investors
Rest of the answer

(i) subscribed for shares, but have not yet completed the purchase of the shares, and such subscription was not for a price at or below $10.00 per share, and (ii) to the extent they are not currently holders of public shares of the Company, the PIPE Investors will not have the right to vote the shares to be purchased in the PIPE at the special meeting of shareholders. As a result, they do not have interests that conflict with, or are not aligned with, the public shareholders that should need disclosure.

Read in the reply
Q: Do I have redemption rights?, page 8
SEC asked (5)
Please fill in missing information throughout the proxy statement/prospectus to the extent that it is known, such as the amounts in this section.
ENVX answered
The Company acknowledges the Staff’s comment and has updated the disclosure throughout the Amended Registration Statement to indicate the balance in the Trust Account and the per share redemption price based upon the amount of funds in the Trust Account as of a recent date before the filing of the Amended Registration Statement. This information will be updated prior to each filing.
Read in the reply
Q: What are the U.S. federal income tax consequences..., page 9
SEC asked (6)
Please revise your disclosure here and on page 107 to clearly state whether the merger will be a taxable transaction. Include risk factor disclosure. In addition, revise the heading on page 107 to remove the word "certain." Refer to Section III of Staff Legal Bulletin No. 19.
ENVX answered
The Company acknowledges the Staff’s comment and has removed the word “certain,” and revised the disclosure on pages 122 through 129 to state whether the merger will be a taxable transaction. The Company has also included Risk

Factor disclosure on page 58.
Read in the reply
Enovix Corporation, page 15
SEC asked (7)
Please revise your disclosure to describe Enovix in more detail. Clarify that it is a development stage company with no operations. Include disclosure about its history of reported losses, and the fact that its independent accounting firm expressed doubt as to its ability to continue as a going concern. Please also add risk factor disclosure describing Enovix's reported losses and the going concern opinion.
ENVX answered
The Company acknowledges the Staff’s comment and has provided additional disclosure on pages 17, 26 and 41 of the

Amended Registration Statement. The Company respectfully advises the Staff that the financial statements of Enovix disclose the factors which indicate that Enovix’s management has substantial doubt about its ability to continue as a going concern. Enovix’s independent accounting firm did not make reference to such conditions in their opinion and therefore it would not be appropriate to attribute any statements regarding going concern to them.
Read in the reply
Parties to the Business Combination · Rodgers Silicon Valley Acquisition Corp, page 15
SEC asked (8)
Please provide the Nasdaq trading price of the securities as of the most recent practicable date.
ENVX answered
The Company acknowledges the Staff’s comment and has provided on page 16 the Nasdaq trading price of the securities as of the most recent practicable date.
Read in the reply
Enovix's relationships with its current customers are subject to various risks, page 32
SEC asked (9)
We note your disclosure that some of Enovix’s customers have exclusive rights to purchase Enovix’s batteries for use in certain ways for certain periods of time, which could limit the ability of Enovix to sell batteries to other customers to which Enovix would otherwise be able to sell batteries. Please revise to elaborate on the exclusive rights and limitations on Enovix.
ENVX answered
The Company acknowledges the Staff’s comment and has provided updated disclosure on page 34 of the Amended Registration

Statement.
Read in the reply
Risk Factors · RSVAC's Sponsor, directors and officers have interests in the Business Combination..., page 48
SEC asked (10)
Please revise your disclosure here to separate the discussion of Mr. Rodgers' conflicts into its own paragraph with its own heading that specifically describes the risk to investors.
ENVX answered
The Company acknowledges the Staff’s comment and has provided a separate risk factor to disclose Mr. Rodger’s conflicts on page 53 of the Amended Registration Statement.
Read in the reply
Risk Factors · RSVAC's Sponsor, directors and officers have interests in the Business Combination..., page 48
SEC asked (11)
Please consider including enhanced disclosure on page 8 and separate risk factor disclosure regarding conflicts of interest of your officers and directors. In that regard, we note that Mr. Reichow is an advisor to RSVAC and was appointed as a director of Enovix. We also note that Mr.
Rest of the question

Schmitt served as an advisor to RSVAC and was hired as the Executive Vice President of Sales of Enovix during the target evaluation process. The Combined Entity's amended and restated certificate of incorporation will..., page 56

ENVX answered
The Company acknowledges the Staff’s comment and has provided enhanced disclosure on pages 83 through 85 and pages

87 and 90 of the Amended Registration Statement, including revising the current risk factor on page 52, to disclose additional conflicts.

We note that neither Mr. Reichow, nor Mr. Schmitt, are members of management or directors of the Company, and did not participate in any of the negotiations, discussions or vote by the directors of the Company with respect to the business combination with Enovix.

Mr.
Rest of the answer

Reichow was appointed as a director of Enovix in

November 2020, prior to the Company’s IPO. Mr. Reichow had served in an advisory role as a member of the Company’s

Technical Advisory Board (“TAB”) prior to that time and continued to serve as a member of TAB after the IPO.

Mr. Reichow did not received any compensation from the Company for serving on TAB and has no interests (economic or otherwise) in the Company that could be deemed to be in conflict with, or do not align with the interests of the public shareholders that we believe requires disclosure in a risk factor.

Mr. Schmitt served as a member of TAB until

January 8, 2021, when he was hired by Enovix as its Vice President of Sales and Business Development. Mr. Schmitt is a member of the Sponsor, which entitles him to receive 10,000 Founder Shares at such time that the Sponsor determines to distribute its assets subsequent to the consummation of the Business Combination. However, Mr. Schmitt does not control the Sponsor, and does not otherwise exercise any control over the Company now, nor did he as an advisor. As a result, we do not believe the

Mr. Schmitt has interests that are that are in conflict with, or do not align with the interests of the public shareholders, which requires disclosure in a risk factor.

We have included enhanced disclosure about their roles as advisors to the Company in response to Comments 14 and 18 below.

Read in the reply
Risk Factors · RSVAC's Sponsor, directors and officers have interests in the Business Combination..., page 48
SEC asked (12)
We note that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. Please also revise your disclosure here on and page 208 to state that there is uncertainty as to whether a court would enforce your provision.
Rest of the question

In that regard, we note Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

ENVX answered
The Company acknowledges the Staff’s comment and has provided updated disclosure on pages 62 and 229 of the

Amended Registration Statement.
Read in the reply
Background of the Business Combination, page 73
SEC asked (13)
Please revise your disclosure in this section to include negotiations relating to material terms of the transaction, including, but not limited to, structure, consideration, proposals and counter-proposals and size of PIPE. In your revised disclosure, please explain the reasons for the terms, each party's position on the issues, and how you reached agreement on the final terms.
ENVX answered
The Company acknowledges the Staff's comment and has added a section beginning on page 92 of the Amended Registration Statement titled, “Negotiation of Material Terms of the Merger Agreement.”
Read in the reply
Background of the Business Combination, page 73
SEC asked (14)
We note your disclosure on page 75 that on December 9, 2020, Mr. Reichow was appointed to the board of directors of Enovix. Please revise to state when he was appointed to the Enovix board. Please also clarify Mr. Reichow's role with RSVAC. Further, we note that throughout this section, you describe Mr. Reichow's involvement, and it not always clear if he is acting as a representative from Enovix or RSVAC.
Rest of the question

In each of your discussion regarding Mr. Reichow involvement please be sure to clarify whether he was acting in his capacity as a representative of RSVAC or Enovix.

ENVX answered
The Company acknowledges the Staff’s comment and has provided clarifying disclosure on pages 83 through 85 and page 90 of the Amended Registration Statement.
Read in the reply
Background of the Business Combination, page 73
SEC asked (15)
We note your disclosure on pages 1 and 75 that Mr. Rodgers would be excluded from future meetings that related to Enovix and RSVAC. Please revise clarify the types of meetings Mr. Rodgers was excluded from. In that regard, we note that Mr. Rodgers participated in meetings that occurred on various dates throughout December and January.
ENVX answered
We have revised the disclosure to clarify that Mr. Rodgers was excluded from all meetings of the Board relating specifically to negotiation of the merger consideration and other material terms of the merger agreement with Enovix, discussions with respect to a business combination with Enovix and the vote of the Board to approve the business combination with Enovix. However, Mr. Rodgers did participate in diligence sessions and other discussions related to business processes and the operations of Enovix.
Rest of the answer

We have clarified disclosure to make that distinction in the Amended Registration Statement.

Read in the reply
Background of the Business Combination, page 73
SEC asked (16)
We note your disclosure on page 83 that Enovix received a fairness opinion prepared by VRC. Please file the fairness opinion as an annex to the proxy statement/prospectus, and include the information required by Item 1015 of Regulation M-A.
ENVX answered
The Company acknowledges the Staff’s comment and has added disclosure on pages 102 through 103 of the Amended Proxy Statement and has attached the opinion prepared by VRC as Annex F thereto. The Company will also filed the consent of VRC as Exhibit 99.10 to the Amended Proxy Statement.

The Company respectfully advises the Staff that, in light of the conflict of interest stemming from Mr.
Rest of the answer

Rodgers’ participation in the Business Combination as the Company’s

Chief Executive Officer and Chairman of the Board and as a member of the board of directors of Enovix, Enovix engaged VRC solely to conduct due diligence and provide an independent review of the Business Combination and consider strategic alternatives consistent with the exercise of the Enovix Special Committee’s fiduciary duties under Delaware law. The reference to the opinion prepared by VRC in the proxy statement/prospectus merely provided the Company’s stockholders with a complete summary of the background of the Business Combination and a full description of the Enovix Special Committee’s robust deliberative process and not because the Company or Enovix regard the information to be relevant or material for the Company’s stockholders to make an informed investment or voting decision on any aspect of the Business Combination.

The opinion prepared by VRC, including its financial analysis, was directed solely to the board of directors of Enovix and designed from Enovix’s perspective only. These materials were neither prepared for nor relied upon by the Company in making its decision to approve the Business Combination and were not shared with the board of directors of the Company or its financial advisors, Oppenheimer & Co. Inc. and ThinkEquity, an independent investment banking firm that rendered a fairness opinion to the board of directors of the Company. Accordingly, the opinion prepared by VRC only addressed the fairness of the consideration to be received by Enovix in the Business Combination from a financial point of view to Enovix and its stockholders and did not address the fairness or appropriateness of the Business Combination to the Company or its stockholders.

Based on these considerations, and given that the

Business Combination does not implicate the heightened disclosure requirements and increased scrutiny for a transaction subject to Rule 13e-3 under the Securities Exchange Act of 1934, as amended, the Company believes the revised disclosures in the Amended Proxy Statement provide its stockholders with all the material information of the Enovix Special Committee’s decision-making process taking into account the material components of VRC’s advice and analysis. Accordingly, we submit that Form S-4 does not require further disclosure to meet the requirements of Item 4(b) of Form S-4, including Item 1015(b)(6) of Regulation M-A

Read in the reply
Background of the Business Combination, page 73
SEC asked (17)
We note your disclosure on page 77 that Enovix needed to demonstrate progress towards improving certain critical business processes. Please revise to disclose the business processes that Enovix needed to improve. We also note your disclosure on page 80 regard RSVAC's Board concerns regarding Enovix's lack of progress in improving certain critical business processes.
Rest of the question

Please elaborate on the nature of the business processes and RSVAC's Board's concerns.

ENVX answered
The Company acknowledges the Staff’s comment and has provided clarifying disclosure on pages 86 and 89 of the Amended

Registration Statement, which elaborate on the nature of the business processes and RSVAC’s Board’s concerns.
Read in the reply
Background of the Business Combination, page 73
SEC asked (18)
Please revise to disclose whether Mr. Schmitt continued as one of RSVAC’s Technical Advisory Board members after he was hired as Executive Vice President of Sales and Marketing of Enovix.
ENVX answered
The Company acknowledges the Staff’s comment and revised to disclose that Mr. Schmitt did not continue as a member of TAB after he was hired as Vice President of Sales and Business Development of Enovix on pages 85 and 87 of the Amended Registration
Read in the reply
Background of the Business Combination, page 73
SEC asked (19)
We note the meeting on January 27, 2021 disclosed on page 80. Please revise to disclose Enterprise Value to be offered to Enovix.
ENVX answered
The Company acknowledges the Staff’s comment and revised to disclose the Enterprise Value to be offered to Enovix on pages 90 through 91 of the Amended Registration Statement.
Read in the reply
Background of the Business Combination, page 73
SEC asked (20)
Please disclose the amount of the valuations and not-to-exceed offer amounts discussed at the various meetings. Please also elaborate on the differing viewpoints and counterpoints discussed at the various meetings.
ENVX answered
The Company acknowledges the Staff’s comment and revised to disclose the amounts discussed at the meetings as well as the differing viewpoints and counterpoints on pages 90 through 92 of the Amended Registration Statement.
Read in the reply
Engagement of Financial Advisor to RSVAC, page 83
SEC asked (21)
Please revise your disclosure to include the compensation paid to ThinkEquity during the past two years including as a result of the current relationship. Refer to Item 1015(4) and (5) of Regulation M-A.
ENVX answered
The Company acknowledges the Staff’s comment and revised the disclosure to include the compensation paid to ThinkEquity during the past two years including as a result of the current relationship on page 93 of the Amended Registration Statement.
Read in the reply
The RSVAC Board's Reasons for the Approval of the Business Combination, page 83
SEC asked (22)
We note that the only reason addressed in this section is the engagement of the financial advisor. Please expand your disclosure here to explain if there were any other positives or negatives that the board considered in determining whether to approve the business combination.
ENVX answered
The Company acknowledges the Staff’s comment and expanded this disclosure by adding a section titled “Other Reasons for the Approval the Business Combination” beginning on page 100 of the Amended Registration Statement.
Read in the reply
PROPOSAL 3: THE CHARTER AMENDMENT PROPOSAL, page 115
SEC asked (23)
Please revise to disclose the amendment to your exclusive forum provision. In that regard, we note that your existing charter provides concurrent jurisdiction for claims arising under the Securities Act, and the proposed charter designates the federal district courts of the United States of America as the exclusive forum for claims arising under the Securities Act.
ENVX answered
The Company acknowledges the Staff’s comment and has updated the disclosure in Proposals 3 and 4 of the Amended

Registration Statement.
Read in the reply
Information About Enovix, page 155
SEC asked (24)
We note your disclosure on page 16 that Enovix was incorporated in 2006. Please revise to provide a brief history of the company's operations.
ENVX answered
The Company acknowledges the Staff’s comment and has provided additional disclosure on page 17 of the Amended Registration
Read in the reply
Information About Enovix, page 155
SEC asked (25)
Please revise to provide the basis for your statement that Enovix's batteries are five years ahead of current industry standard products.
ENVX answered
The Company acknowledges the Staff’s comment and has provided additional disclosure on pages 17 and 175 of the Amended Registration Statement.
Read in the reply
Information About Enovix, page 155
SEC asked (26)
Please elaborate on the terms of your funded product development agreements. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration.
Rest of the question

Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

ENVX answered
The Company acknowledges the Staff’s comment and has provided additional disclosure on page 175 of the Amended Registration

Statement. The Company respectfully advises the Staff that it has changed the description of these agreements to “Service Revenue contracts” to conform to how these agreements are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Enovix” and “Enovix Corporation—Notes to Consolidated Financial Statements” and to more accurately reflect the nature of these agreements.
Read in the reply
Risk Factors, page 31
SEC asked (1)
We note your response comment 11 of our prior letter. Please include appropriate risk factor disclosure regarding potential conflicts of interest of Mr. Reichow, who served as an advisor to RSVAC and a board member of Enovix, and Mr. Schmitt, who served as an advisor to RSVAC and an officer of Enovix.
ENVX answered
The Company acknowledges the Staff's comment and has provided additional disclosure on pages 9, 25, 55, 70 and 128 of the Amended Registration Statement. The Company respectfully advises the Staff that while Mr. Reichow did provide some advisory services to the Company's Technical Advisory Board ("TAB"), he received no compensation from the Company for such services. In addition, Mr. Reichow informed the Board of Directors of the Company of his appointment to the Board of Directors of Enovix, after which Mr.
Rest of the answer

Reichow and the Board of Directors of the Company determined that he would continue to provide the Company with information on the Company's target companies as a member of the TAB, but would no longer participate in the Company's meetings regarding target companies. In addition, Mr. Reichow disclosed his service on the TAB to the Board of Directors of Enovix, and such service was taken into consideration by the Enovix board with respect to Mr. Reichow's participation in the Enovix board's deliberations.

As we indicated in our letter dated May 10, 2021, we do not believe that Mr. Schmitt has interests that are that are in conflict with, or do not align with the interests of, the public shareholders, which would require disclosure in a risk factor. Mr. Schmitt has been an employee of Enovix since January 8, 2021, as its Vice President of Sales and Business Development. While Mr. Schmitt is also a member of the Sponsor, which would entitle him to receive 10,000 Founder

Shares at such time that the Sponsor determines to distribute its assets subsequent to the consummation of the Business Combination, Mr.

Schmitt does not control the Sponsor, and does not exercise any control over the Company.

Read in the reply
RSVAC's Chief Executive Officer and Chairman of the Board has interests in, page 53
SEC asked (2)
Please disclose Mr. Rodgers' ownership interest in Combined Entity.
ENVX answered
As disclosed in the table beginning on page 244, Mr. Rodgers’ ownership interest in the Combined Entity will be 22,687,628 shares of RSVAC Common stock, or 16.0% (assuming no redemptions) or 17.9% (assuming maximum redemptions).​ These shares consist of

(i) the 5,750,000 shares of RSVAC Common Stock owned by Rodgers Capital, LLC, and (ii) 16,937,628 shares of Combined Entity common stock held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which Mr. Rodgers is trustee. We have added similar disclosure in the risk factor devoted to Mr.
Rest of the answer

Rodgers that begins on page 56 of the Amended Registration Statement.

Read in the reply
Background of the Business Combination, page 81
SEC asked (3)
We note your response to comment 20 of our prior letter. Please revise to identify the comparable companies discussed during negotiations. Please also elaborate on the differing viewpoints and counterpoints discussed at the various meetings.
ENVX answered
The Company acknowledges the Staff’s comment and has provided updated disclosure beginning on page 95 of the Amended Registration Statement.
Read in the reply
Background of the Business Combination, page 81
SEC asked (4)
We note your meeting on January 27, 2021. Please disclose the proposed valuation of Enovix, the methods and bases used towards the proposed Total Enterprise Value, comparable companies’ valuations and other other analyses provided by Oppenheimer.
ENVX answered
The Company acknowledges the Staff’s comment and has provided updated disclosure beginning on page 93 of the Amended Registration Statement.
Read in the reply
Background of the Business Combination, page 81
SEC asked (5)
Please elaborate on the nature of the discussions at the PIPE Financing meetings.
ENVX answered
The Company acknowledges the Staff’s comment and has provided updated disclosure beginning on page 96 of the Amended Registration Statement.
Read in the reply
Background of the Business Combination, page 81
SEC asked (6)
We note that the financial advisory services fees for Oppenheimer are contingent upon the business combination closing. Please disclose the amount of the advisory fees.
ENVX answered
The Company acknowledges the Staff’s comment and has provided updated disclosure beginning on page 92 of the Amended Registration Statement.
Read in the reply
Projected Financial Information, page 92
SEC asked (7)
We note your disclosure on page 95 that the financial projections are based on a variety of operational assumptions, including the number of battery cells sold and the average sales price and that key assumptions impacting the forecast include projected cost of material and manufacturing, research and development, selling, general and administrative expenses, capital expenditures and asset financing, among others.
Rest of the question

Please revise to describe such estimates and assumptions with greater specificity and quantify where practicable.

ENVX answered
The Company acknowledges the Staff's comment and has provided updated disclosure on page 101 of the Amended Registration Statement.
Read in the reply
Projected Financial Information, page 92
SEC asked (8)
We note your disclosure that the projections on page 93 were prepared by Enovix. Please also include financial projections and assumptions prepared by RSVAC's management.
ENVX answered
The Company acknowledges the Staff’s comment and respectfully informs the Staff that there were no financial projections and assumptions prepared by RSVAC's management. The Company has added clarifying disclosure beginning on page 99 of the Amended

Registration Statement.
Read in the reply
Material U.S. Federal Income Tax Considerations of the Business Combination, page 127
SEC asked (9)
It appears from your revisions in response to comment 6 that you do not represent that the merger will be a taxable transaction. As a result, please file a tax opinion by amendment and include the opinion in the exhibit index.
Rest of the question

If counsel elects to file a short form tax opinion, both the opinion and the information in the joint proxy statement/prospectus must state clearly that the discussion in the joint proxy statement/prospectus constitutes counsel's opinion. Please revise your prospectus disclosure to provide a firm conclusion regarding treatment of the transaction under Section 368 and remove language stating that it is intended that certain material tax consequences will apply. Refer to Item 601(b)(8) of Regulation S-K and to Section III of Staff Legal Bulletin No. 19 for guidance.

ENVX answered
The Company acknowledges the Staff's comment and has filed tax opinions as Exhibits 5.2 and 5.3 to the Amended Registration Statement and provided additional disclosure regarding tax treatment on pages 129 and 134 of the Amended Registration Statement and has provided additional risk factor disclosure on page 60 of the Amended Registration Statement.
Read in the reply
Information About Enovix, page 175
SEC asked (10)
We note your response to comment 26 of our prior letter. Please revise to clarify the term of your Service Revenue Contracts, the time period to reach certain milestones and the termination rights of the parties.
ENVX answered
The Company acknowledges the

Staff's comment and has provided updated disclosure beginning on page 182 of the Amended Registration Statement.
Read in the reply
SEC asked (1)
Please ensure that all other missing information is included in a pre-effective amendment, including the fee that will be paid to MacKenzie Partners on pages 14 and 71, the committee assignments beginning on page 202, and any information that is dependent on the record date, to the extent that the record date has been set.
ENVX answered
The Company respectfully advises the Staff that it has included all of the missing information throughout the Amended Registration Statement, including the fee to be paid to MacKenzie Partners, the committee assignments, and the information that is dependent on the record date. The Company also advises the Staff that, as discused on our phone call on June 17, 2021, a record date of June 11, 2021 and a stockholders meeting date of July 12, 2021 has been set.
Read in the reply
SEC asked (2)
We note your disclosure that Enovix has relied on a $15 million short-term bridge loan from Mr. Rodgers to support its business operations. Please revise pages 8 and 247 to disclose the Bridge Note entered into in May 2021. Please also disclose, if true, that the Bridge Note will be repaid from funds from the Trust and PIPE.
Rest of the question

Q: What interests do RSVAC's current officers and directors have in the Business Combination?,

ENVX answered
The

Company respectfully advises the Staff that it has revised the disclosure in the Amended Registration Statement beginning on pages

9, 25, 44, 57, 72, 130 and 249 to provide that the Bridge Note will be repaid at the closing of the business combination from funds available from the Trust and the PIPE.
Read in the reply
SEC asked (3)
We note your response to comment 4 of our letter dated April 5, 2021. Since it appears that the PIPE Investors will be purchasing the shares at a discount to the current market price, please provide the requested disclosure regarding the value of the PIPE investor interests.
ENVX answered
The Company respectfully advises the Staff that it has revised the disclosure in the Amended Registration Statement on pages 6, 113 and

128 to provide the value of the PIPE investor shares based on the closing price of RSVAC’s Common Stock of $20.00 on Nasdaq as of the Record Date.
Read in the reply
Background of the Business Combination, page 85
SEC asked (4)
We note your revisions in response to comment 6. Please provide the dollar amounts of the transaction fee and the placement fee.
ENVX answered
The Company respectfully advises the Staff that it has revised the disclosure in the Amended Registration Statement on page 94 to provide the dollar value of these fees.
Read in the reply

Form S-1

2020-11-10 to 2020-11-30 · 1 question · 1 letter from the SEC, 3 from the company
No closing letter
Financial Statements · Note 8 - Subsequent Events, page F-13
SEC asked
We note that your auditors completed field work and issued their report on your financial statements on October 14, 2020. We further note that footnote 8 to your financial statements is incomplete as to the date your financial statements were available to be issued.
Rest of the question

Please clarify for us how your auditors were able to issue their report if it remains unknown when your financial statements will be available to be issued.

ENVX answered
Note 8-Subsequent

Events on page Page F-13 of the Amended Registration Statement has been revised in accordance with the Staff’s comments.
Read in the reply

Also in this review: company letter, Nov 30, 2020, company letter, Nov 30, 2020

Letters without questions

Other letters

UPLOAD and CORRESP
5 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 21 letters filed since 2020-11-10. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ENVX/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.